Amarin Corp PLC (AMRN)
0.8857
+0.01
(+0.65%)
USD |
NASDAQ |
Apr 24, 16:00
0.8798
-0.01
(-0.67%)
After-Hours: 20:00
Amarin Free Cash Flow: 6.347M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.347M |
| September 30, 2023 | 9.053M |
| June 30, 2023 | -16.49M |
| March 31, 2023 | -88.25M |
| December 31, 2022 | -180.09M |
| September 30, 2022 | -209.88M |
| June 30, 2022 | -196.21M |
| March 31, 2022 | -146.68M |
| December 31, 2021 | -66.54M |
| September 30, 2021 | -76.62M |
| June 30, 2021 | -61.23M |
| March 31, 2021 | -44.59M |
| December 31, 2020 | -22.00M |
| September 30, 2020 | 7.025M |
| June 30, 2020 | 16.61M |
| March 31, 2020 | 30.13M |
| December 31, 2019 | -11.84M |
| September 30, 2019 | -34.85M |
| June 30, 2019 | -83.50M |
| March 31, 2019 | -123.04M |
| December 31, 2018 | -94.76M |
| September 30, 2018 | -64.59M |
| June 30, 2018 | -42.66M |
| March 31, 2018 | -28.72M |
| December 31, 2017 | -32.85M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.02M |
| June 30, 2017 | -62.47M |
| March 31, 2017 | -60.84M |
| December 31, 2016 | -71.84M |
| September 30, 2016 | -75.76M |
| June 30, 2016 | -79.59M |
| March 31, 2016 | -96.33M |
| December 31, 2015 | -84.05M |
| September 30, 2015 | -76.74M |
| June 30, 2015 | -74.06M |
| March 31, 2015 | -59.76M |
| December 31, 2014 | -74.61M |
| September 30, 2014 | -91.77M |
| June 30, 2014 | -116.73M |
| March 31, 2014 | -158.20M |
| December 31, 2013 | -190.35M |
| September 30, 2013 | -213.25M |
| June 30, 2013 | -208.04M |
| March 31, 2013 | -176.82M |
| December 31, 2012 | -135.00M |
| September 30, 2012 | -90.96M |
| June 30, 2012 | -59.63M |
| March 31, 2012 | -48.86M |
| December 31, 2011 | -39.84M |
| September 30, 2011 | -37.43M |
Free Cash Flow Range, Past 5 Years
-209.88M
Minimum
Sep 2022
30.13M
Maximum
Mar 2020
-61.56M
Average
-44.59M
Median
Mar 2021
Free Cash Flow Benchmarks
| Trinity Biotech PLC | -12.92M |
| DBV Technologies SA | -80.33M |
| Adaptimmune Therapeutics PLC | -145.76M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -8.842M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.645M |
| Cash from Investing (Quarterly) | -71.00M |
| Cash from Financing (Quarterly) | 0.083M |
| Free Cash Flow Per Share (Quarterly) | -0.0028 |
| Free Cash Flow to Equity (Quarterly) | -1.154M |
| Free Cash Flow to Firm (Quarterly) | -1.154M |
| Free Cash Flow Yield | 1.76% |